Skip to main content

COVID-19 Topic Center

Psoriatic Arthritis News

News
The prevalence of metabolic syndrome is significantly higher in patients with psoriatic arthritis compared with patients with ankylosing spondylitis, suggests a study of outpatients at single hospital over a 15-month period. Researchers published their findings online in BMC Musculoskeletal…
News
In a network meta-analysis, guselkumab for psoriatic arthritis outperformed most other agents for patients’ Psoriasis Area Severity Index (PASI) 75/90 response and offered arthritis efficacy comparable to IL-17A and subcutaneous tumor necrosis factor (TNF) inhibitors. Researchers published their…
News
Generalized pustular psoriasis (GPP) and palmoplantar pustulosis (PPP) are associated with a substantial economic burden in the United States, according to a study published online ahead of print in the journal Current Medical Research and Opinion.  Researchers from Boehringer Ingelheim…
News
Patients who initiated apremilast for the treatment of psoriatic arthritis had significantly lower healthcare costs over 12 months than those who initiated a biologic, even when they ended up switching from apremilast to a biologic, according to a study published in Current Medical Research and…
News
Patients who used oral immunotherapies for chronic inflammatory joint and skin diseases were more likely to switch medications than those who used injectable immunotherapies, but total healthcare costs were lower with oral therapies, according to a study published in the Journal of Managed Care…
News
With its focus on lifestyle factors such as diet, physical activity, and environment exposures, functional medicine may be a helpful adjunct for patients with inflammatory arthritis who do not improve with standard care alone, according to a study published online in PLOS One.  “In this…
News
While the majority of patients initiating pharmacologic treatment for psoriatic arthritis started with oral small molecule (OSM) monotherapy, mediation persistence was poorer, and treatment modifications more common, with index OSMs compared with index tumor necrosis factor inhibitors (TNFis),…
News
Secukinumab could be a more efficient first biologic option than adalimumab to treat patients with psoriatic arthritis, according to a study published online in the journal Reumatología Clínica. The cost-consequence analysis took a Spanish National Health System perspective to investigate…
News
Compared with their peers in the general population, young adults with psoriatic arthritis are at increased mortality risk, according to a study published in the journal Seminars in Arthritis and Rheumatism.  “Better control of comorbidities may reduce this risk,” researchers advised. The study…
Conference Insider
While the correlation between musculoskeletal symptoms, patient-reported outcomes, and ultrasonography findings is poor in patients with psoriasis with suspected psoriatic arthritis (PsA), musculoskeletal ultrasonography (MSK-US) provides additional information for clinical assessment and aids in…
Back to Top